Bristol Myers Squibb Appoints New Chief Medical Officer

Ticker: CELG-RI · Form: 8-K · Filed: Feb 18, 2025 · CIK: 14272

Bristol Myers Squibb Co 8-K Filing Summary
FieldDetail
CompanyBristol Myers Squibb Co (CELG-RI)
Form Type8-K
Filed DateFeb 18, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: executive-appointment, compensation, leadership-change

Related Tickers: BMY

TL;DR

BMS names Dr. Samit Hirawat as new CMO, effective Feb 14, with $750K salary + bonus.

AI Summary

Bristol Myers Squibb Company announced on February 18, 2025, that its Board of Directors appointed Dr. Samit Hirawat as Executive Vice President and Chief Medical Officer, effective February 14, 2025. Dr. Hirawat will also serve as a principal executive officer. He previously held the role of Executive Vice President, Oncology, and will receive a base salary of $750,000, with potential for a target annual bonus of 120% of his base salary.

Why It Matters

The appointment of a new Chief Medical Officer is a significant leadership change that could influence the company's strategic direction in drug development and clinical trials.

Risk Assessment

Risk Level: low — This filing primarily concerns an executive appointment and compensation, which typically carries a low inherent risk.

Key Numbers

  • $750,000 — Base Salary (Dr. Samit Hirawat's annual compensation)
  • 120% — Target Bonus (Dr. Samit Hirawat's potential annual bonus)

Key Players & Entities

  • Bristol Myers Squibb Company (company) — Registrant
  • Dr. Samit Hirawat (person) — Appointed Executive Vice President and Chief Medical Officer
  • $750,000 (dollar_amount) — Dr. Hirawat's base salary
  • 120% (dollar_amount) — Dr. Hirawat's target annual bonus percentage
  • February 14, 2025 (date) — Effective date of appointment
  • February 18, 2025 (date) — Date of report

FAQ

Who has been appointed as the new Executive Vice President and Chief Medical Officer at Bristol Myers Squibb?

Dr. Samit Hirawat has been appointed as the new Executive Vice President and Chief Medical Officer.

When was Dr. Samit Hirawat's appointment effective?

Dr. Samit Hirawat's appointment was effective February 14, 2025.

What is Dr. Samit Hirawat's base salary?

Dr. Samit Hirawat's base salary is $750,000.

What is the target annual bonus percentage for Dr. Samit Hirawat?

The target annual bonus for Dr. Samit Hirawat is 120% of his base salary.

What previous role did Dr. Samit Hirawat hold at Bristol Myers Squibb?

Dr. Samit Hirawat previously held the role of Executive Vice President, Oncology.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 by Dr. Samit Hirawat regarding BRISTOL MYERS SQUIBB CO (CELG-RI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.